Abstract

Summary

This study investigates how Alzheimer's disease disrupts circadian rhythms and causes retinal degeneration in a mouse model, highlighting the interconnection between neurodegeneration, the light/dark cycle, and melatonin signaling. For lighting designers and healthcare providers, these findings suggest that supporting robust light/dark entrainment may be particularly important for Alzheimer's patients to help preserve circadian function and potentially slow retinal and neurological decline.
Abstract

Key Findings

  • Alzheimer's disease mouse models show disturbed circadian rhythms alongside retinal degeneration, suggesting a dual pathway of pathology affecting both timekeeping and visual systems.
  • Melatonin is regulated by the environmental light/dark cycle via the suprachiasmatic nucleus and plays roles in sleep regulation, antioxidant defense, antiapoptotic signaling, and cytoprotection relevant to neurodegenerative diseases.
  • Melatonin analogs such as agomelatine have shown efficacy in treating major depressive disorder and bipolar affective disorder, and melatonin itself has documented utility in circadian rhythm sleep disorders including jet lag and shift-work sleep disorder.
Categories

Categories

Dementia & Elder Care: Examines circadian rhythm disturbances and retinal degeneration in an Alzheimer's disease mouse model, with implications for light-based interventions in dementia care.
Sleep & Circadian Health: Discusses melatonin's role as a chronobiotic and sleep facilitator, including its regulation by the light/dark cycle via the suprachiasmatic nucleus.
Eye Health & Vision: Addresses retinal degeneration as a feature of Alzheimer's disease pathology, connecting retinal health to circadian disruption.
Authors

Author(s)

L Carrero, D Antequera, I Alcalde, D MegĂ­as
Publication Date

Publication Year

2023
Citations

Number of Citations

5
View more publications